Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Professional development

Five-year review of pharmacists’ CPD to be kept for now, says GPhC

Duncan Rudkin (pictured), the chief executive of the General Pharmaceutical Council (GPhC), said it had decided against rescheduling the CPD timetable because it might confuse registrants

Source: General Pharmaceutical Council (GPhC)

General Pharmaceutical Council chief executive Duncan Rudkin said it had decided against rescheduling the CPD timetable because it might confuse pharmacists

The pharmacy regulator has decided to keep to the existing five-year cycle for pharmacists to present evidence of their continuing professional development (CPD) while it decides on the future of the “call and review” system. 

The General Pharmaceutical Council (GPhC) is advising pharmacists to continue to follow their own personal CPD timetable and to record evidence as normal. 

Duncan Rudkin, the regulator’s chief executive, said it had decided against rescheduling the CPD timetable when its council met on 10 September 2015 because it might confuse registrants. 

“The reason not to reschedule was quite simple – we didn’t want to confuse people. We want people to continue with business as usual,” he said. 

The advice comes as the GPhC continues to work out the detail of its reforms to move away from a five-year CPD cycle to an annual CPD audit which relies on calling in a random selection of CPD records for assessment. 

For the first time the GPhC has come up with a figure for the percentage of records which could be recalled each year. 

It said that if 2.5% of records were selected the number would be statistically significant, and it would mean that pharmacists would be assessed more often than they are now and it would be likely that everybody would know somebody who was being assessed at any one time. 

But Rudkin said the 2.5% was just an illustrative figure and no decision has yet been taken. “I think it is the first time that we have put out a figure but no figure has been agreed,” he said. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069380

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Duncan Rudkin (pictured), the chief executive of the General Pharmaceutical Council (GPhC), said it had decided against rescheduling the CPD timetable because it might confuse registrants

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.